Tesla (TSLA) Stock: GigaShanghai Tagged as Future Optimus Robot Manufacturing Hub

Key Takeaways

• Wang Hao, Tesla China’s president, identified GigaShanghai as a critical facility for achieving large-scale Optimus production
• This represents the initial public confirmation from Tesla leadership regarding Shanghai’s involvement in humanoid robot assembly
• The Shanghai facility manufactured 851,000 vehicles during 2025, representing over half of Tesla’s worldwide production volume
• Tesla’s Fremont facility is simultaneously being repurposed for humanoid robot assembly operations
• Elon Musk’s compensation structure requires delivery of one million Optimus units before 2035

Tesla’s Chinese manufacturing powerhouse may expand beyond automotive production. On Tuesday, Wang Hao, president of Tesla China, revealed that the Shanghai Gigafactory possesses the capabilities to manufacture Optimus humanoid robots and could become instrumental in ramping up production volumes.

Wang described GigaShanghai as the “golden key” for overcoming mass production obstacles related to Optimus — representing the first instance of a Tesla executive publicly identifying Shanghai as a prospective robotics manufacturing location.

According to Wang, the facility can “shoulder important responsibilities in manufacturing all new products, including robots,” and he conveyed optimism about “welcoming the arrival of a new era of robots.”

Wang stopped short of clarifying whether Tesla plans to repurpose current Shanghai infrastructure or construct dedicated robotics facilities.

GigaShanghai stands as Tesla’s most expansive and efficient manufacturing operation. Throughout 2025, the plant delivered approximately 851,000 vehicles — accounting for 52% of the company’s worldwide production. During Q1 specifically, the facility’s deliveries jumped 23.5% compared to the previous year, reaching 213,398 vehicles and comprising 59.6% of Tesla’s quarterly global production.

Tesla, Inc., TSLA

The Shanghai operation currently manages both Model 3 and Model Y assembly for Chinese customers and international markets. Additionally, the facility launched Megapack battery production in the previous year, with targets set at 10,000 units per year.

Shanghai’s Strategic Manufacturing Advantages

The Chinese facility offers multiple strategic benefits for robotics production: cutting-edge automation systems, experienced labor force, and proximity to extensive supplier ecosystems. These elements align precisely with requirements for complex humanoid robot manufacturing at industrial scale.

Elon Musk has openly recognized the challenges inherent in scaling Optimus production. However, GigaShanghai’s established operational framework provides Tesla with significant foundational advantages.

Optimus represents Tesla’s vision for an accessible, functional humanoid robot — positioned at $20,000 to $30,000 price points. The robot operates on a 2.3 kWh battery system, features bipedal locomotion, reaches maximum speeds near 5 mph, and incorporates dexterous hands capable of precision manipulation.

Simultaneously, Tesla is transforming its Fremont manufacturing complex — previously the production home for Model S and Model X vehicles, both discontinued — into a specialized humanoid robot assembly center.

Musk’s recently approved compensation arrangement, potentially valued up to $1 trillion, hinges on achieving delivery of one million Optimus robots by 2035. This performance benchmark explains the accelerated push toward production scaling.

Competitive Landscape in Robotics

Musk has been candid regarding Tesla’s primary robotics competitor. During January’s earnings discussion, he identified China as “by far the biggest competition” in the humanoid robot sector, praising the nation as “incredibly good at scaling manufacturing.”

He further asserted that Tesla’s Optimus remains “much more capable than any robot we are aware of under development in China,” though recognizing advancements from competitors including XPeng, which targets 1,000 IRON robot units monthly and envisions one million yearly sales by 2030.

Government-backed manufacturers Changan and Chery are similarly pursuing humanoid robot development. Nio has adopted a more cautious approach, stating it will delay robotics investment until achieving consistent financial profitability.

Current Wall Street consensus rates TSLA as Hold, reflecting 13 Buy recommendations, 11 Hold ratings, and 6 Sell opinions across the most recent three-month period. Analysts’ average price target stands at $402.29, suggesting approximately 10.5% potential appreciation.